Mia's Feed
Medical News & Research

Innovative Rapid and Comfort-Driven Breast Imaging Technology Shows Promise in Early Clinical Trials

Innovative Rapid and Comfort-Driven Breast Imaging Technology Shows Promise in Early Clinical Trials

Share this article

A new rapid, pain-free breast imaging system combining photoacoustic and ultrasound technologies shows great potential in early clinical testing, promising improved detection and patient comfort for breast cancer screening.

2 min read

A groundbreaking breast imaging system that is quick, non-invasive, and highly comfortable has demonstrated promising results in initial clinical evaluations. The system, known as OneTouch-PAT, utilizes a combination of photoacoustic and ultrasound imaging techniques to detect breast cancer more efficiently and with less discomfort than traditional methods. Unlike mammography, which involves painful compression and radiation exposure, this new approach allows women to stand naturally and gently press their breast against an imaging window, completing scans in under a minute.

In early testing involving four healthy volunteers and 61 breast cancer patients, OneTouch-PAT successfully generated detailed 3D images powered by artificial intelligence, highlighting common breast cancer subtypes such as Luminal A, Luminal B, and Triple-Negative Breast Cancer. The images revealed distinct vascular patterns associated with each cancer type, providing valuable insights into tumor characteristics.

Developed by researchers at the University at Buffalo, led by Professor Jun Xia, Ph.D., the system integrates advanced imaging, automation, and AI to improve detection accuracy and patient experience. The technology automates the combined photoacoustic and ultrasound scans, reducing operator dependency and potential errors, and processes the data rapidly, often within minutes.

This innovation is particularly promising for women with dense breast tissue, a group for whom traditional imaging techniques may be less effective. The complementary nature of the photoacoustic and ultrasound components allows for better visualization of suspicious lesions and blood vessel growth around tumors, which are critical markers of malignancy.

While the initial results are encouraging, further research involving larger and more diverse populations is planned to validate and refine OneTouch-PAT. The future developments aim to incorporate additional sensors and more sophisticated imaging tools to enhance speed and precision.

Supported by the National Institutes of Health, this technology could significantly augment existing breast cancer screening methods, potentially leading to earlier and less painful detection, ultimately saving more lives.

Source: https://medicalxpress.com/news/2025-07-quick-pain-free-breast-imaging.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Global Vaccine Stockpiles Play Crucial Role in Preventing Over 5.8 Million Disease Cases

Research shows that global vaccine stockpiles have prevented over 5.8 million disease cases and saved thousands of lives, highlighting the importance of rapid outbreak response and maintained immunization coverage.

Breakthrough Discovery Links DNA Complex to Resistance in Cancer Polymerase Inhibitors

This groundbreaking study uncovers how dysfunction in a DNA repair complex contributes to resistance against PARP inhibitor therapy in BRCA1-deficient cancers, opening new avenues for treatment enhancement.

Combined Depression and Inflammation Linked to Poorer Outcomes in Lung Cancer Patients

Research reveals that lung cancer patients with high depression and inflammation levels at diagnosis experience persistent depressive symptoms, highlighting the importance of early screening to improve outcomes.

Innovative Approach to Dopamine Disorders by Targeting Kappa Opioid Receptors

New research suggests that blocking kappa opioid receptors may offer a safer, effective approach to treating dopamine-related neuropsychiatric disorders by normalizing dopamine transporter function and reducing behavioral deficits.